Alzheimer's Club

A forum for non-censored ideas, news, research and technology on Alzheimer's disease


			_


							_

Alzheimer's cure: World General Media News Headlines

Alzheimer's treatment: World General Media News Headlines

Alzheimer theories: World General Media News Headlines

Alzheimer science professional news: Alzforum News & Views

April 01, 2006

ISAI, DNAVEC Join in Drug Discovery Research for Alzheimer's Disease

Tokyo (31 March 2006) - Eisai has signed an agreement with DNAVEC on drug discovery research for Alzheimer's disease (AD). Under the agreement, the two companies aim to develop a vaccine therapy for AD.

Specifically, using DNAVEC's proprietary Sendai virus vector, they plan to develop a gene vaccine that can selectively induce the production of anti-beta amyloid antibodies. Beta amyloid is considered to play a role in preventing and suppressing the progress of AD.

Eisai has a prior right to develop, manufacture and sell results obtained from the partnership.

Source: Jcn, JCN Staff Writer JCN (31 March 2006) [FullText]

0 Comments:

Latest PubMed 20 review articles on Alzheimer’s

Latest PubMed 20 research articles on Alzheimer’s amyloid

Latest PubMed 50 research titles on Alzheimer’s

AlzClub Lay and Science News content is under automatic continuous update. Please check back often or subscribe to news of interest using RSS feed buttons below. Also, please email to us your news terms suggestions
A semi-fiction mystery novel "The Alzheimer Code" is under preparation. In this book the death of the President of the United States of America is followed by his preventive anti-amyloid vaccination against Alzheimer's disease. At the same time and for the same reason, in his agony of death Editor-in-Chief of London-based Nature science journal recalls he in fact witnessed the corruption of Alzheimer's pseudo-science, brought to the community by a keen student. This is a story of a corrupted Harvard University professor, a research center co-director and a godfather of the international network of science criminals. Be the first to know when Alzheimer Code is published, by subscribing to an AlzClub.org news alerts . Otherwise automate your Alzheimer’s information portfolio with a number of options presented at this page.
Subscribe to AlzClub Mailing List, and freely share your information directly with your peers by e-mail. Click here to prepare email message requesting AlzClub Mailing List subscription
Would you like to author articles at Alzheimer's Club? Then send us your masterpiece, so we can screen it and publish at Alzclub.org. Please note that comments (on articles published previously) can be posted directly and anonymously (but why you would stay not known to the public?)
Do you know that as of May 3, 2005 NIH asks NIH-funded scientists to deposit their articles (published earlier in scientific journals) in PubMedCentral (PMC)? PMC is accessible to all for free and is one form of the academic world movement towards Public Open Access to scholar literature, free from commercial publishers' cabal. New to Open Access? Then you miss important science publishing development, because an NIH provision became a US law at the end of 2007. Read lay language article on Open Access authored by AlzClub founder. NIH-funded authors: visit the NIH Manuscript Submission system for more information.